Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

Michael Mingzhao Xing*, Ali S. Alzahrani, Kathryn A. Carson, David Viola, Rossella Elisei, Bela Bendlova, Linwah Yip, Caterina Mian, Federica Vianello, R. Michael Tuttle, Eyal Robenshtok, James A. Fagin, Efisio Puxeddu, Laura Fugazzola, Agnieszka Czarniecka, Barbara Jarzab, Christine J. O'Neill, Mark S. Sywak, Alfred K. Lam, Garcilaso Riesco-EizaguirrePilar Santisteban, Hirotaka Nakayama, Ralph P. Tufano, Sara I. Pai, Martha A. Zeiger, William H. Westra, Douglas P. Clark, Roderick Clifton-Bligh, David Sidransky, Paul W. Ladenson, Vlasta Sykorova

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

787 Scopus citations

Fingerprint

Dive into the research topics of 'Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science